DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Molgramostim
Molgramostim
The Impact of Biosimilar Competition in Europe December 2020
Autoimmune Pulmonary Alveolar Proteinosis in an Adolescent Successfully Treated with Inhaled Rhgm-CSF
Lenograstim and Filgrastim in the Febrile Neutropenia Prophylaxis Open Access to Scientific and Medical Research DOI
Role of Cytokines As a Double-Edged Sword in Sepsis
Comparative Safety of Filgrastim Versus Sargramostim in Patients Receiving Myelosuppressive Chemotherapy
PDCO Minutes of the 20-23 February 2018 Meeting
Mobilization of Peripheral Blood Stem Cells Following Myelosuppressive Chemotherapy: a Randomized Comparison of Filgrastim, Sarg
The Impact of Biosimilar Competition in Europe Contents
Pharmacology of Recombinant Or Genetically Engineered Drugs
Pam378 Lipegfilgrastim Lonquex Neutropenia
1 the PREVENTION of ORAL SIDE EFFECTS of CANCER TREATMENT VOLUME I of II a Thesis Submitted to the University of Manchester
And G-CSF (filgrastim) After Cyclophosphamide (4 G/M2) Enhance the Peripheral Blood Progenitor Cell Harvest: Results of Two Randomized Studies Including 120 Patients
Evaluation of Effectiveness of Granulocyte-Macrophage Colony-Stimulating Factor Therapy to Cancer Patients After Chemotherapy: a Meta-Analysis
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
WO 2017/017187 Al 2 February 2017 (02.02.2017) P O PCT
Are All Gfs Equal? How Say I?
Top View
Production Design of Efficient Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Under a Gene-Specific Promoter in Prokaryotic System
Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantat
The Impact of Biosimilar Competition June 2016 the Impact of Biosimilar Competition Introduction
Haematological Malignancies
The Impact of Biosimilar Competition in Europe Contents
Molgramostim (GM-CSF) Associated with Antibiotic Treatment in Nontraumatic Abdominal Sepsis a Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease
COMP Minutes 17-19 May 2016
A Randomized Study Comparing Filgrastim Versus Lenograstim Versus Molgramostim Plus Chemotherapy for Peripheral Blood Progenitor
(Neulasta) in Patients with Sickle Cell Trait/Anemia
Managing Sarcoma: Where Have We Come from and Where Are We Going?
New Therapies Haemopoietic Growth Factors
Perioperative Recombinant Human Granulocyte Colony-Stimulating Factor (Filgrastim) Treatment Prevents Immunoinflammatory Dysfunc
Synthesis of Granulocyte–Macrophage Colony- Stimulating Factor As Homogeneous Glycoforms and Early Comparisons with Yeast Cell-Derived Material
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor: Effect of Glycosylation on Pharmacokinetic Parameters
A View Into Upcoming Specialty & Traditional Drugs
Pulmonary Alveolar Proteinosis in Children
HEMATOPOIETIC AGENTS;GROWTH FACTORS,MINERALS and VITAMINS Phr.Volkan KAHRAMAN HGF’S
Insulin O Phospholipid Patent Application Publication Apr
Animals Induced by DNA Vaccination of Outbred T Cell Responses + Antigen-Specific CD4 Inoculation Site and Enhance Increase Dend
Neoadjuvant GM-CSF and Modulation of the Immune Cell Profile of the SLN in Primary Cutaneous Stage I-III Melanoma NCT# 02451488
Blood in Vitro Glucocorticoid-Immunosuppressed
(PDCO) Draft Agenda for the Meeting on 11-14 December 2018
Hematopoietic Growth Factors As Biopharmaceuticals
Potential Clinical Applications of Rhgm-CSF in Acute Myeloid
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Annals of Oncology 9: 877-884, 1998
Hematopoietic Growth Factors in Oncology (Cancer Treatment and Research, Vol. 157)
Novel Agents and Approaches for Stem Cell Mobilization in Normal Donors and Patients
Case Report Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia